Form 8-K Edwards Lifesciences For: Jul 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Edwards Lifesciences (EW) shares decline as growth disappoints investors
July 27, 2023 12:19 PM EDTShares of Edwards Lifesciences (NYSE: EW) declined after it reported second quarter results. Despite solid earnings per share and revenue, growth rates disappointed investors.
Edwards Lifesciences reported second quarter sales that were slightly above consensus at $1.53 billion. At $0.66, EPS topped consensus by a penny.
The company expects full year 2023 sales to be between $5.9 billion and $6.1 billion. For the year, the company expects transcatheter aortic... More



